Modulation of thiol homeostasis induced by H2S-releasing aspirin

Free Radical Biology and Medicine

Volumn 48, Issue 9, 2010, Pages 1263-1272

  Giustarini, Daniela ^a   Del Soldato, Piero ^b   Sparatore, Anna ^c   Rossi, Ranieri ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b CTG Pharma   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

glutamyltranspeptidase; Aspirin; Cysteine; Dithiolethione; Hydrogen sulfide; Thiols

Indexed keywords

1,2 DITHIOLE 3 THIONE DERIVATIVE; 5 (4 HYDROXYPHENYL) 3H 1,2 DITHIOLE 3 THIONE; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID DERIVATIVE; ACS 14; CYSTEINE; GLUTATHIONE; HOMOCYSTEINE; THIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; HOMEOSTASIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANETHOLE TRITHIONE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTATHIONE; HOMEOSTASIS; HYDROGEN SULFIDE; RATS; RATS, SPRAGUE-DAWLEY; SULFHYDRYL COMPOUNDS;

RATTUS;

EID: 77950340742     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.02.014     Document Type: Article

References (50)

1. Zhang Y., Munday R. Dithiolethiones for cancer chemoprevention: where do we stand?. Mol. Cancer Ther. 2008, 7:3470-3479.
2. Sparatore A., Perrino E., Tazzari V., Giustarini D., Rossi R., Rossoni G., Erdman K., Schröder H., Del Soldato P. Pharmacological profile of a novel H2S-releasing aspirin. Free Radic. Biol. Med. 2009, 46:586-592.
3. Li L., Rossoni G., Sparatore A., Lee L.C., Del Soldato P., Moore P.K. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic. Biol. Med. 2007, 42:706-719.
4. Perrino E., Cappelletti G., Tazzari V., Giavini E., Del Soldato P., Sparatore A. New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity. Bioorg. Med. Chem. Lett. 2008, 18:1893-1987.
5. Muzaffar S., Jeremy J.Y., Sparatore A., Del Soldato P., Angelini G.D., Shukla N. H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br. J. Pharmacol. 2008, 155:984-994.
6. Khanna S., Sen C.K., Roy S., Christen M.O., Packer L. Protective effects of anethole dithiolethione against oxidative stress-induced cytotoxicity in human Jurkat T cells. Biochem Pharmacol. 1998, 56:61-69.
7. Buetler T.M., Gallagher E.P., Wang C., Stahl D.L., Hayes J.D., Eaton D.L. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, Ethoxyquin, and Oltipraz. Toxicol. Appl. Pharmacol. 1995, 135:45-57.
8. Ansher S.S., Dolan P., Bueding E. Chemoprotective effects of two dithiolthiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity. Hepatology 1983, 3:932-935.
9. Rossi R., Milzani A., Dalle-Donne I., Giannerini F., Giustarini D., Lusini L., Colombo R., Di Semplicio P. Different metabolizing ability of thiol reactants in human and rat blood: biochemical and pharmacological implications. J. Biol. Chem. 2001, 276:7004-7010.
10. Li L., Bhatia M., Zhu Y.Z., Zhu Y.C., Ramnath R.D., Wang Z.J., Anuar F.B., Whiteman M., Salto-Tellez M., Moore P.K. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005, 19:1196-1198.
11. Giustarini D., Perrino E., Tazzari V., Rossi R. HPLC determination of novel dithiolethione containing drugs and its application for in vivo studies in rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878:340-346.
12. Yoshida D., Todo H., Hasegawa T., Sugibayashi K. Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition. Int. J. Pharm. 2007, 337:142-147.
13. Giustarini D., Dalle-Donne I., Lorenzini S., Milzani A., Rossi R. Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:1030-1038.
14. Giustarini D., Dalle-Donne I., Paccagnini E., Milzani A., Rossi R. Carboplatin-induced alteration of the thiol homeostasis in the isolated perfused rat kidney. Arch. Biochem. Biophys. 2009, 488:83-89.
15. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
16. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol. 1985, 113:484-490.
17. Aebi H Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
18. Çiftçi M., Bilici D., Küfrevioǧlu O.I. Effects of melatonin on enzyme activities of glucose-6-phosphate dehydrogenase from human erythrocytes in vitro and from rat erythrocytes in vivo. Pharmacol Res. 2001, 44:7-11.
19. Flohé L., Günzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
20. Roth E.F., Gilbert H.S. The pyrogallol assay for superoxide dismutase: absence of a glutathione artifact. Anal. Biochem. 1984, 137:50-53.
21. Holmgren A., Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 1995, 252:199-208.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
23. Di Iorio E.E. Preparation of derivatives of ferrous and ferric hemoglobin. Methods Enzymol. 1981, 76:57-72.
24. Mansoor M.A., Svardal A.M., Ueland P.M. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem. 1992, 200:218-229.
25. Jones D.P., Mody V.C., Carlson J.L., Lynn M.J., Sternberg P. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic. Biol. Med. 2002, 33:1290-1300.
26. Moriarty-Craige S.E., Jones D.P. Extracellular thiols and thiol/disulfide redox in metabolism. Annu. Rev. Nutr. 2004, 24:481-509.
27. Ookhtens M., Kaplowitz N. Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin. Liver Dis. 1998, 18:313-329.
28. Davies M.H., Blacker A.M., Schnell R.C. Dithiolthione-induced alterations in hepatic glutathione and related enzymes in male mice. Biochem. Pharmacol. 1987, 36:568-570.
29. O'Dwyer P.J., Szarka C.E., Yao K.S., Halbherr T.C., Pfeiffer G.R., Green F., Gallo J.M., Brennan J., Frucht H., Goosenberg E.B., Hamilton T.C., Litwin S., Balshem A.M., Engstrom P.F., Clapper M.L. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J. Clin. Invest. 1996, 98:1210-1217.
30. Rossoni G., Sparatore A., Tazzari V., Manfredi B., Del Soldato P., Berti F. The hydrogen sulphide-releasing derivative of diclofenac protects against ischemia-reperfusion injury in isolated rabbit heart. Br. J. Pharm. 2008, 15:100-109.
31. Li L., Moore P.K. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?. Trends Pharmacol. Sci. 2008, 29:84-90.
32. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008, 322:587-590.
33. Kimura Y., Dargusch R., Schubert D., Kimura H. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid. Redox Signal. 2006, 8:661-670.
34. Becker J.C., Domschke W., Pohle T. Current approaches to prevent NSAID-induced gastropathy-COX selectivity and beyond. Br. J. Clin. Pharmacol. 2004, 58:587-600.
35. Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., Hammond C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 2009, 390:191-214.
36. Bass S.E., Sienkiewicz P., Macdonald C.J., Cheng R.Y., Sparatore A., Del Soldato P., Roberts D.D., Moody T.W., Wink D.A., Yeh G.C. Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. Clin. Cancer Res. 2009, 15:1964-1972.
37. Ansher S.S., Dolan P., Bueding E. Biochemical effects of dithiolthiones. Food Chem. Toxicol. 1986, 24:405-415.
38. Bueding E., Dolan P., Leroy J.P. The antischistosomal activity of oltipraz. Res. Commun. Chem. Pathol. Pharmacol. 1982, 37:293-303.
39. Rao C.V., Rivenson A., Katiwalla M., Kelloff G.J., Reddy B.S. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res. 1993, 53:2502-2506.
40. Giustarini D., Milzani A., Dalle-Donne I., Rossi R. Red blood cells as a physiological source of glutathione for extracellular fluids. Blood Cells Mol. Dis. 2008, 40:174-179.
41. Beutler E., Dale G Erythrocyte glutathione: function and metabolism. Coenzymes and Cofactors, Glutathione - Chemical, Biochemical, and Medical Aspects, part B 1989, III:291-317. John Wiley & Sons, New York. D. Dolphin, R. Poulson, O. Avramovic (Eds.).
42. Kaplowitz N., Fernández-Checa J.C., Kannan R., Garcia-Ruiz C., Ookhtens M., Yi J.R. GSH transporters: molecular characterization and role in GSH homeostasis. Biol. Chem. Hoppe Seyler. 1996, 377:267-273.
43. Griffith O.W. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 1999, 27:922-935.
44. Mosharov E., Cranford M.R., Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000, 39:13005-13011.
45. Vitvitsky V., Mosharov E., Tritt M., Ataullakhanov F., Banerjee R. Redox regulation of homocysteine- dependent glutathione synthesis. Redox Rep. 2003, 8:57-63.
46. Martín J.A., Pereda J., Mart í nez-L ó pez I., Escrig R., Miralles V., Pallard ó F.V., Vina J.R., Vento M., Vina J., Sastre J. Oxidative stress as a signal to up-regulate gamma-cystathionase in the fetal-to-neonatal transition in rats. Cell. Mol. Biol. 2007, 53:1010-1017.
47. Kimura Y., Goto Y., Kimura H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid. Redox Signal. 2010, 12:1-13.
48. Pompella A., Corti A., Paolicchi A., Giommarelli C., Zumino F. Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Curr. Opin. Pharmacol. 2007, 7:360-366.
49. Giral P., Jacob N., Dourmap C., Hansel B., Carriè A., Bruckert E., Girerd X., Chapman M.J. Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb. Vasc. Biol. 2008, 28:587-593.
50. Bradley A., Maron M.D., Loscalzo J. The treatment of hyperhomocysteinemia. Annu. Rev. Med. 2009, 60:39-54.